-+ 0.00%
-+ 0.00%
-+ 0.00%

Candel Therapeutics files Form 3 for Chief Commercial Officer Mark E. Sims

PUBT·07/08/2026 20:12:43
Listen to the news
Candel Therapeutics files Form 3 for Chief Commercial Officer Mark E. Sims
  • Candel Therapeutics filed a Form 3 naming Mark E. Sims as chief commercial officer in an initial statement of beneficial ownership dated July 6, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Candel Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002139479-26-000003), on July 08, 2026, and is solely responsible for the information contained therein.